Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check6 days agoChange DetectedThe page's update history now shows new dates (2026-02-17 and 2026-02-18) and removes older dates (2026-02-10 and 2026-02-11); the changes affect only the update timeline and not the core study details.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.4.2 was added on 2026-02-10 and 2026-02-11, while Revision: v3.4.1 entries were removed on 2026-02-03 and 2026-02-04.SummaryDifference0.1%

- Check20 days agoChange DetectedUpdates are limited to routine metadata changes, including a new revision flag (Revision: v3.4.1) and recent update dates (2026-02-04, 2027-03-19, 2026-02-03, 2026-01). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check27 days agoChange DetectedShow glossary was added; minor copy changes include the phrasing of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new footer note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedUpdated study record dates include additions on 2026-01-20 and 2026-01-16, and deletions on 2026-01-13 and 2026-01-10. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdministrative updates were logged: new revision notes (v3.3.4) dated 2026-01-10 and 2026-01-13, and deletions of earlier revisions (v3.3.3) dated 2026-01-03 and 2026-01-06. These changes do not modify the trial data, eligibility criteria, or outcomes presented on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.